Riskpilot← Back to searchSign inGet full accessScriptomist ApS
APSActiveCVR 42004901Hyldemorvej 31Activities of advertising agencies · NACE 7311Est. 20211 employeeshttps://scriptomist.com/
Revenue 2024
DKK -15K
-101% vs 2023
EBITDA margin
861.5%
+13% vs 2023
Equity ratio
-69.8%
Financial strength
Net profit 2024
DKK -161K
+48% vs 2023
| Revenue | DKK -15K | -101% |
| EBITDA | DKK -132K | +13% |
| Net profit | DKK -161K | +48% |
| Total assets | DKK 497K | -52% |
| Equity | DKK -347K | -86% |
| Employees | 1 | — |
Legal name
Scriptomist ApS
CVR number
42004901
Legal form
Anpartsselskab
NACE code
7311 · Activities of advertising agencies
Founded
8. januar 2021
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af den administrerende direktør i forening med et bestyrelsesmedlem eller af to bestyrelsesmedlemmer.
Company purpose
Selskabets formål er at drive virksomhed med content marketing og hermed forbundet virksomhed.
Address
Hyldemorvej 31
Phone
+4570601001
Email
service@wedigitize.dk
Website
https://scriptomist.com/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 3.625 | 3.883 | 1.603 | -15 |
| Staff expenses | -3.553 | -3.835 | -1.755 | -116 |
| EBITDA | 72 | 47 | -152 | -132 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | 72 | 47 | -152 | -132 |
| Net financials | -4 | -1 | -192 | -29 |
| Profit before tax | 68 | 46 | -344 | -161 |
| Tax | 15 | 14 | -33 | -0 |
| Net profit | 53 | 32 | -311 | -161 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1.661 | 1.663 | 1.031 | 497 |
| Equity | 93 | 124 | -187 | -347 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 1.568 | 1.539 | 1.218 | 845 |
| Total debt | 1.568 | 1.539 | 1.218 | 845 |
EBITDA margin
-13174800.0%
This company
15.8%
Market median
-83384910% vs market
20212024
Equity ratio
-69.8%
This company
38.2%
Market median
-283% vs market
20212024
Return on equity
-16076000.0%
This company
18.4%
Market median
-87369665% vs market
20212024
Net profit margin
-16076000.0%
This company
8.1%
Market median
-198469236% vs market
20212024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20212024
Debt / equity
2.43×
This company
0.62×
Market median
-292% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-08 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TF Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
TR Management | Management | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
visibility.group ApS | Company | 100.0% | 100.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
3MJ HOLDING ApS
Scriptomist ApS Board members of Scriptomist ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Feltendahl Dinesen | Chief Executive Officer | 0 companies |
| Thomas Ramstedt-Helt | Management | 0 companies |
| Mark Thorsen | Chairman | 0 companies |
| Jørgen Nordahl Kristensen | Board of Directors | 0 companies |
| Martin Leo Mansikkamäki Jørgensen | Chairman | 0 companies |